Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged in A) 100 Count Bottles (NDC: 64679-0735-02), B) 500…
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
43 FDA recalls mention Metoprolol. The most recent are listed below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Metoprolol.
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason CGMP Deviations: Firm did not adequately investigate customer complaints.
Reason Failed Dissolution Specifications: Dissolution failures found during testing of control samples at the four hour time point.
Reason Presence of Foreign Tablets/Capsules: A pharmacist reported a rogue tablet of different size and markings in bottle of Metoprolol
Reason Failed Dissolution Specifications: Failure of dissolution test observed at the 18 month time point.
Reason Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long term stability testing point.
Reason Failed Dissolution Specifications: Failure of dissolution test observed at three month time point.
Reason Failed Dissolution Specifications: failure of dissolution test observed at nine month time point.
Reason Failed Dissolution Specification; 12-Month stability interval.
Reason Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 25 mg may have potentially been mislabeled as the following drug: DOCUSATE SODIUM, Capsule, 250…
Reason Labeling: Label Mixup: METOPROLOL TARTRATE, Tablet, 50 mg may have potentially been mislabeled as one of the following drugs: METOPROLOL TARTRATE…
Reason Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as PIOGLITAZONE, Tablet, 15 mg, NDC…
Reason Labeling:Label Mixup; METOPROLOL SUCCINATE ER, Tablet, 200 mg may be potentially mislabeled as Pedigree: AD73652_13, EXP: 5/30/2014.
Reason Labeling:Label Mixup; METOPROLOL TARTRATE, Tablet, 25 mg may be potentially mislabeled as ASCORBIC ACID, Tablet, 250 mg, NDC 00904052260…
Reason Labeling:Label Mixup; METOPROLOL TARTRATE Tablet, 12.5 mg (1/2 of 25 mg) may be potentially mislabeled as DOCUSATE SODIUM, Capsule, 250 mg, NDC…
Reason Lack of Assurance of Sterility: all sterile products compounded, repackaged, and distributed by this compounding pharmacy due to lack of sterility…
Reason Tablet Thickness: Potential for some tablets not conforming to weight specifications (under and over weight)
Tell us which medications you take. If the FDA recalls one, we email you - in plain English, with what to do. Free.